← Research library

Tesamorelin

Growth hormone axis · By Preptide Pro editorial team · Last updated

Tesamorelin is a growth hormone axis peptide, and it has an FDA-approved product. A synthetic GHRH analogue. Approved by the FDA to reduce excess abdominal fat in adults with HIV-associated lipodystrophy.

FDA-approved (see products)

Chemistry (PubChem)

PubChem CID16137828
CAS number218949-48-5
Molecular formulaC221H366N72O67S
Molecular weight5136 g/mol
Other namesTesamorelin, TH9507, TH 9507, tesamorelina, tesamoreline, tesamorelinum, TH-9507, CHEBI:63626

Is Tesamorelin FDA-approved?

FDA application records from openFDA
BrandApplicationStatusSponsor
EGRIFTABLA022505PrescriptionTHERATECHNOLOGIES

How much research is there on Tesamorelin?

PubMed lists 122 records for “tesamorelin”, of which 28 are tagged as human clinical trials.

Most recent PubMed records
Recent studyJournalDate
Peptides in urology and sexual medicine: clinical effectiveness, dosing, indications, and safety: a narrative review.Sex Med Rev2026 Sep 30
The effect of growth hormone-releasing hormone on cognition and brain connectivity in adults with cognition ranging from normal to mild cognitive impairment.eNeurologicalSci2026 Sep
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.Sports Med2026 Aug
Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV (TRIUMPH): a clinical trial protocol.BMJ Open2026 Jul 8
The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.Front Endocrinol (Lausanne)2026

Sources

This is general research information, not medical advice. Check with a clinician before using any compound.

Preptide Pro is a tracking tool, not medical advice. Talk to a clinician about any treatment.